Clinical Trials in San Diego

Showing 7021-7040 of 11,146 trials

Novel PI3K Delta Inhibitor TGR-1202, in Combination With Brentuximab Vedotin for Hodgkin's Lymphoma Patients

NCT02164006

The purpose of this study is to evaluate the safety and effectiveness of TGR-1202 in combination with brentuximab vedotin in patients with hodgkin's lymphoma.

Hodgkin's Lymphoma

TG Therapeutics, Inc.16 participantsStarted Jun 2014

Duarte, California, United States • San Diego, California, United States • Sarasota, Florida, United States +1 more locations

COMPLETEDNA< 1 mile

Effects of Surfactants on the Innate Immune System

NCT01951352

In this study we will test the ability of different commercially available hand soaps to effect the amount of anti-microbial peptides present on the surface of the human skin after washing with these soaps. Based on our experiments on pig skin, we expect the amount of antimicrobial peptide expression to decrease after using these different soaps.

Healthy

University of California, San Diego10 participantsStarted Sep 2013

San Diego, California, United States

COMPLETEDPhase 2< 1 mile

A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease

NCT01683409

This is a dose ranging study to evaluate the safety and efficacy of baricitinib in the treatment of participants with mild to moderate diabetic kidney disease.

Diabetic Kidney Disease

Eli Lilly and Company130 participantsStarted Aug 2012

Lancaster, California, United States • San Diego, California, United States • Torrance, California, United States +42 more locations

Novel PI3K Delta Inhibitor TGR-1202, in Combination With Brentuximab Vedotin for Hodgkin's Lymphoma Patients

Effects of Surfactants on the Innate Immune System

A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease

Find Trials by Condition in San Diego

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

Oxytocin Add-on for Stable Depressed Patients

Evaluation of the CooperVision, Inc. Fanfilcon A and Enfilcon A Daily Wear Contact Lenses When Used for Frequent Replacement for up to One (1) Month of Daily Wear

A Study in Second Line Metastatic Colorectal Cancer

A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR"

A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris

Safety and Feasibility of ADRCs Treatment To Patients With Thermal Wounds

MRI to Detect Breast Tumors in Women

A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)

Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa

Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing

MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer

A Study in Advanced Solid Tumors

Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)

Study of Ramucirumab in Ovarian Cancer